Biotech bellwether Gilead Sciences shares sagged after reporting a blockbuster quarter. Here's what investors need to know before they sell too. Imagine owning Amazon.com (up over an insane... | From: The Motley Fool Views: 16 0 ratings | |
| Time: 08:57 | More in News & Politics |
Healthcare: 3 Things You Ought to Know About Gilead's Tumble *** INDUSTRY FOCUS ***
0 commentaires:
Enregistrer un commentaire